Log In
Print this Print this


Also known as: PNT100

  Manage Alerts
Collapse Summary General Information
Company ProNAi Therapeutics Inc.
Description24-base phosphodiester DNA sequence targeting the B cell lymphoma 2 (BCL-2; BCL2) gene formulated with Marina Biotech's Smarticles liposomal delivery technology
Molecular Target B cell lymphoma 2 (BCL-2) (BCL2)
Mechanism of ActionBcl-2 inhibitor; Gene silencing
Therapeutic ModalityNucleic acid: Linear DNA

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today